ABOUT US

Paving the Way to a Brighter Future

Our regenerative therapy aims to meet this clinical need and offer a treatment, not only for the refractory group of patients for whom medical therapy, angioplasty and coronary bypass surgery have failed to control the disease, but also for patients much earlier in the treatment pathway.

Gene Therapy

Genetic opportunities for disease therapy

The aim of treating CAD with gene therapy is to cause regenerative changes and to improve myocardial blood flow. Therapeutic vascular growth is a new concept for the treatment of ischemic vascular diseases. It involves stimulation of angiogenesis, arteriogenesis, and induction of regenerative changes via activation of stem/progenitors cells.

This project has received funding from the European Union's Horizon 2020 research and innovation progamme under grant agreement No 731532.

©2020 by ReGenHeart